Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
INO
|
Jacqueline Elizabeth Shea
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 28,336 Reduced 42.37% |
$425,890
$15.03 p/Share
|
Feb 01
2021 |
|
PHAT
|
Azmi Nabulsi
Chief Operating Officer |
SELL
Open market or private sale
|
Indirect | 5,416 Reduced 0.66% |
$206,295
$38.09 p/Share
|
Feb 01
2021 |
|
VRNA
|
Anders Ullman
Director |
SELL
Open market or private sale
|
Direct | 10,800 Reduced 3.02% |
$10,692
$0.99 p/Share
|
Feb 01
2021 |
|
VRNA
|
Vikas Sinha
Director |
SELL
Open market or private sale
|
Direct | 10,224 Reduced 10.8% |
$10,122
$0.99 p/Share
|
Feb 01
2021 |
|
VRNA
|
Mahendra Shah
Director |
SELL
Open market or private sale
|
Direct | 10,800 Reduced 11.42% |
$10,692
$0.99 p/Share
|
Feb 01
2021 |
|
VRNA
|
Martin Edwards
Director |
SELL
Open market or private sale
|
Direct | 13,688 Reduced 10.01% |
$13,551
$0.99 p/Share
|
Feb 01
2021 |
|
VRNA
|
David R Ebsworth
Director |
SELL
Open market or private sale
|
Direct | 11,912 Reduced 1.68% |
$11,793
$0.99 p/Share
|
Feb 01
2021 |
|
VRNA
|
Kenneth Cunningham
Director |
SELL
Open market or private sale
|
Direct | 13,104 Reduced 14.12% |
$12,973
$0.99 p/Share
|
Feb 01
2021 |
|
ALPN
|
Mitchell Gold
Executive Chairman and CEO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 3.23% |
$126,400
$12.64 p/Share
|
Feb 01
2021 |
|
PSNL
|
Richard Chen
CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct | 40,000 Reduced 32.05% |
$1,539,600
$38.49 p/Share
|
Feb 01
2021 |
|
KOPN
|
Paul Christopher Baker
Kopin COO |
SELL
Open market or private sale
|
Direct | 16,250 Reduced 6.0% |
$83,363
$5.13 p/Share
|
Feb 01
2021 |
|
FIXX
|
Timothy P Kelly
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 100.0% |
$49,480
$12.37 p/Share
|
Feb 01
2021 |
|
RDI
|
Margaret Cotter
Chairperson, EVP - RE Dev/NY |
SELL
Open market or private sale
|
Indirect | 4,000 Reduced 0.24% |
$22,200
$5.55 p/Share
|
Feb 01
2021 |
|
RDI
|
James J. Cotter Living Trust
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 0.24% |
$22,200
$5.55 p/Share
|
Feb 01
2021 |
|
RDI
|
Ellen M Cotter
Director, President and CEO |
SELL
Open market or private sale
|
Indirect | 4,000 Reduced 0.24% |
$22,200
$5.55 p/Share
|
Feb 01
2021 |
|
AXLA
|
Manu Chakravarthy
SVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 18,472 Reduced 30.79% |
$101,596
$5.5 p/Share
|
Feb 01
2021 |
|
SURF
|
Jeff Goater
Director |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 0.95% |
$26,725
$10.69 p/Share
|
Feb 01
2021 |
|
SURF
|
Jessica Fees
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 1.47% |
$16,785
$11.19 p/Share
|
Feb 01
2021 |
|
MMNFF
|
Wicklow Capital Inc.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 171,210 Reduced 0.97% |
$32,530
$0.19 p/Share
|
Feb 01
2021 |
|
CRTX
|
Casey Lynch
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 0.31% |
$739,800
$36.99 p/Share
|
Feb 01
2021 |
|
MLSS
|
Giandomenico Trombetta
Director |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 0.3% |
$84,600
$2.82 p/Share
|
Feb 01
2021 |
|
KOSS
|
Steven A Leveen
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 100.0% |
$390,300
$39.03 p/Share
|
Feb 01
2021 |
|
KOSS
|
Thomas L. Doerr
Director |
SELL
Open market or private sale
|
Direct | 6,667 Reduced 100.0% |
$280,147
$42.02 p/Share
|
Feb 01
2021 |
|
KOSS
|
William Jesse Sweasy
Director |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 100.0% |
$800,000
$40.0 p/Share
|
Feb 01
2021 |
|
KOSS
|
Theodore Nixon
Director |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 100.0% |
$1,313,400
$43.78 p/Share
|
Feb 01
2021 |
|
KOSS
|
Lenore Lillie
VP - Operations |
SELL
Open market or private sale
|
Direct | 84,487 Reduced 89.33% |
$4,244,627
$50.24 p/Share
|
Feb 01
2021 |
|
KOSS
|
David Donnan Smith
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 149,000 Reduced 100.0% |
$7,064,090
$47.41 p/Share
|
Feb 01
2021 |
|
KOSS
|
Michael J Koss Jr
VP - Marketing & Product |
SELL
Open market or private sale
|
Direct | 91,052 Reduced 66.44% |
$3,491,844
$38.35 p/Share
|
Feb 01
2021 |
|
KOSS
|
John C Koss Jr
Vice President - Sales |
SELL
Open market or private sale
|
Indirect | 97,779 Reduced 24.07% |
$4,460,678
$45.62 p/Share
|
Feb 01
2021 |
|
KOSS
|
John C Koss Jr
Vice President - Sales |
SELL
Open market or private sale
|
Direct | 285,000 Reduced 47.01% |
$11,117,850
$39.01 p/Share
|
Feb 01
2021 |
|
KOSS
|
Michael J Koss
President and CEO |
SELL
Open market or private sale
|
Indirect | 104,000 Reduced 7.59% |
$4,765,280
$45.82 p/Share
|
Feb 01
2021 |
|
KOSS
|
Michael J Koss
President and CEO |
SELL
Open market or private sale
|
Direct | 190,000 Reduced 18.56% |
$7,746,300
$40.77 p/Share
|
Feb 01
2021 |
|
SMED
|
John W Dalton |
SELL
Open market or private sale
|
Direct | 21,281 Reduced 2.36% |
$276,227
$12.98 p/Share
|
Feb 01
2021 |
|
SMED
|
Diana P Diaz
Senior Vice President & CAO |
SELL
Open market or private sale
|
Direct | 1,765 Reduced 17.07% |
$23,404
$13.26 p/Share
|
Feb 01
2021 |
|
TESS
|
Joseph Cawley
Senior Vice President |
SELL
Open market or private sale
|
Direct | 2,761 Reduced 39.38% |
$21,204
$7.68 p/Share
|
Feb 01
2021 |
|
FREQ
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct | 33,102 Reduced 9.7% |
$1,427,027
$43.11 p/Share
|
Feb 01
2021 |
|
AAOI
|
Chih Hsiang (Thompson) Lin
President and CEO |
SELL
Open market or private sale
|
Direct | 2,507 Reduced 0.34% |
$28,078
$11.2 p/Share
|
Feb 01
2021 |
|
APLT
|
Riccardo Perfetti
Chief Medical Officer |
BUY
Open market or private sale
|
Direct | 2,325 Added 77.89% |
$59,218
$25.47 p/Share
|
Feb 01
2021 |
|
APLT
|
Riccardo Perfetti
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 1,460 Reduced 100.0% |
$37,084
$25.4 p/Share
|
Feb 01
2021 |
|
TSRI
|
Fintech Consulting, LLC |
SELL
Open market or private sale
|
Indirect | 376,000 Reduced 100.0% |
$2,726,000
$7.25 p/Share
|
Feb 01
2021 |
|
EGIO
|
Robert A Lento
CEO |
SELL
Open market or private sale
|
Direct | 20,833 Reduced 1.09% |
$95,415
$4.58 p/Share
|
Feb 01
2021 |
|
WORK
|
Allen Shim
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 25,302 Reduced 9.22% |
$1,074,070
$42.45 p/Share
|
Feb 01
2021 |
|
WORK
|
Cal Henderson
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 4,279 Reduced 9.49% |
$181,644
$42.45 p/Share
|
Feb 01
2021 |
|
WORK
|
Brandon Zell
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 3,999 Reduced 2.24% |
$169,758
$42.45 p/Share
|
Feb 01
2021 |
|
WORK
|
David Schellhase
General Counsel and Secretary |
SELL
Open market or private sale
|
Direct | 3,323 Reduced 1.02% |
$141,061
$42.45 p/Share
|
Feb 01
2021 |
|
WORK
|
Robert Frati
Sr VP Sales, Customer Success |
SELL
Open market or private sale
|
Direct | 9,574 Reduced 3.03% |
$406,416
$42.45 p/Share
|
Feb 01
2021 |
|
MA
|
Foundation Mastercard |
SELL
Open market or private sale
|
Direct | 57,198 Reduced 0.05% |
$18,273,618
$319.48 p/Share
|
Feb 01
2021 |
|
ZM
|
Bart Swanson
Director |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 100.0% |
$736,900
$368.45 p/Share
|
Feb 01
2021 |
|
SPRO
|
Aquilo Capital Management, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 13,661 Reduced 0.35% |
$262,838
$19.24 p/Share
|
Feb 01
2021 |
|
GNTX
|
Matthew Chiodo
Vice President of Sales |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 12.88% |
$165,300
$33.06 p/Share
|
Feb 01
2021 |